Related Experiment Video
Updated: Mar 20, 2026

08:54
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
15.1K
Isotoxic radiosurgery planning for brain metastases
Omar Bohoudi1, Anna M E Bruynzeel1, Frank J Lagerwaard1
1Dept. Of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands.
Summary
This study introduces a new formula to determine the optimal radiosurgery (RS) dose for brain metastases (BM), minimizing radionecrosis (RN) risk. The formula uses lesion volume to personalize treatment, improving patient outcomes.
Area of Science:
- Radiation Oncology
- Neurosurgery
- Medical Physics
Background:
- Radionecrosis (RN) is a known complication of radiosurgery (RS) for brain metastases (BM).
- Previous studies linked RN to RS dose, lesion volume, and brain dose parameters like V10-14Gy.
- Optimizing RS dose is crucial for balancing tumor control and normal brain toxicity.
Purpose of the Study:
- To develop a knowledge-based, individualized method for estimating the optimal RS dose.
- To create a prediction model for brain toxicity parameters and optimal RS dose based on lesion characteristics.
- To provide a practical formula for personalized RS dose prescription.
Main Methods:
- A prediction model was derived using 30 historical RS plans for single BM (0.2-20.3cc).
- The model involved deriving formulas for V10-18Gy prediction and establishing relationships with prescription dose and lesion volume.
- Validation was performed on 65 new patients with 138 BM lesions treated with VMAT.
Main Results:
- A linear relationship was found between planning target volume (PTV) size and brain toxicity parameters (V10-18Gy).
- An individualized RS prescription dose formula was derived: PD=[V12Gy+0.96+(1.44×PTV)]/[0.12+(0.12×PTV)].
- High correlation (R²=0.991) was observed between predicted and actual V12Gy in the validation cohort.
Conclusions:
- A simple, effective formula is proposed for estimating optimal individual RS dose for BM.
- The formula accounts for lesion volume and normal brain toxicity parameters (V12Gy).
- This approach enables personalized RS dose selection to mitigate radionecrosis risk.

